Clinical Trials Logo

Cardiovascular Diseases clinical trials

View clinical trials related to Cardiovascular Diseases.

Filter by:

NCT ID: NCT00113711 Completed - Clinical trials for Cardiovascular Diseases

Promoting Smoking Cessation and Reducing Weight Gain

Start date: January 1995
Phase: N/A
Study type: Interventional

To test whether a behavioral intervention could indeed achieve the dual goals of promoting smoking cessation and minimizing weight gain.

NCT ID: NCT00113672 Completed - Clinical trials for Cardiovascular Diseases

Make Better Choices Study

MBC
Start date: August 2004
Phase: N/A
Study type: Interventional

The purpose of this study is to examine the impact of diet and exercise on an individual's health.

NCT ID: NCT00113074 Completed - Hypertension Clinical Trials

Preventing Weight Gain and Controlling Blood Pressure During Smoking Cessation in Hypertensive Smokers

Start date: September 2004
Phase: N/A
Study type: Interventional

The purpose of this study is to develop effective interventions that assist individuals with high blood pressure to quit smoking and prevent weight gain.

NCT ID: NCT00113061 Completed - Obesity Clinical Trials

Effect of Exercise on Elevated C-reactive Protein Concentrations in Formerly Inactive Adults

Start date: July 2004
Phase: N/A
Study type: Interventional

The purpose of this study is to determine the effect of exercise training on elevated C-reactive protein (CRP) concentrations, an indicator of inflammation, in initially inactive women and men.

NCT ID: NCT00111059 Recruiting - Obesity Clinical Trials

Primary Prevention Study: Study on Obesity, Cardiovascular and Psycho-Social Characteristics in the City of Merzig

Start date: January 2005
Phase: N/A
Study type: Observational

Cardiovascular risk factors and psycho-social characteristics will be determined in obese and non-obese patients in the setting of primary medical care.

NCT ID: NCT00110201 Recruiting - Clinical trials for Cardiovascular Disease

The Use of Nesiritide in Thoracic Aneurysm Repair to Prevent Acute Renal Failure

Start date: March 2005
Phase: Phase 3
Study type: Interventional

The purpose of this trial is to study the use of nesiritide in thoracic aneurysm repair to prevent acute renal failure. The study hypothesis: Nesiritide, given prophylactically prior to surgery may prevent acute renal failure requiring dialysis and/or decrease mortality.

NCT ID: NCT00106951 Completed - Clinical trials for Cardiovascular Diseases

Effects of Neighborhood SES on Coronary Heart Disease Burden in Communities - Ancillary to ARIC

Start date: April 2005
Phase: N/A
Study type: Observational

To investigate the role of racial and socioeconomic disparities in coronary heart disease (CHD) mortality in the United States.

NCT ID: NCT00106886 Active, not recruiting - Stroke Clinical Trials

HOPE-2 Study (Heart Outcomes Prevention Evaluation-2 Study)

Start date: December 1999
Phase: Phase 4
Study type: Interventional

The purpose of the HOPE-2 study is to determine whether long term supplementation with folic acid, vitamins B6 and B12 aimed at homocyst(e)ine reduction reduces the rates of major fatal and nonfatal cardiovascular events in patients with established cardiovascular disease and/or diabetes mellitus.

NCT ID: NCT00106483 Completed - Clinical trials for Cardiovascular Diseases

Autoimmunity and Coronary Artery Disease - Ancillary to CARDIA

Start date: February 2005
Phase: N/A
Study type: Observational

To test the primary hypothesis that individuals with pre-clinical connective tissue disease related autoimmunity are more likely to demonstrate subsequent development of sub-clinical coronary artery disease.

NCT ID: NCT00106457 Completed - Obesity Clinical Trials

20 Year Changes in Fitness & Cardiovascular Disease Risk - Ancillary to CARDIA

Start date: February 2005
Phase: N/A
Study type: Observational

To understand the complex, longitudinal relations between physical fitness, physical activity, body mass and composition and fat distribution, and genetic factors and their independent or interactive effects on the development of obesity, the metabolic syndrome, and sub-clinical cardiovascular disease.